Yüklüyor......
Comet assay measures of DNA damage as biomarkers of irinotecan response in colorectal cancer in vitro and in vivo
The use of irinotecan to treat metastatic colorectal cancer (CRC) is limited by unpredictable response and variable toxicity; however, no reliable clinical biomarkers are available. Here, we report a study to ascertain whether irinotecan-induced DNA damage measures are suitable/superior biomarkers o...
Kaydedildi:
| Yayımlandı: | Cancer Med |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4567016/ https://ncbi.nlm.nih.gov/pubmed/26108357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.477 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|